Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
Open accessThe DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Abstract
The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of gastric cancer (GC) was published in 2016, and covered the management and treatment of local, locoregional, locally advanced and metastatic disease. At the ESMO Asia Meeting in November 2017 it was decided by both ESMO and The Japanese Society of Medical Oncology (JSMO) to convene a special guidelines meeting immediately after the JSMO Annual Meeting in 2018. The aim was to adapt the ESMO 2016 guidelines to take into account the ethnic differences associated with the treatment of metastatic GC in Asian patients. These guidelines represent the consensus opinions reached by experts in the treatment of patients with metastatic GC representing the oncological societies of Japan (JSMO), China (CSCO), Korea (KSMO), Malaysia (MOS), Singapore (SSO) and Taiwan (TOS). The voting was based on scientific evidence and was independent of both the current treatment practices and the drug availability and reimbursement situations in the individual participating Asian countries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Bang, Y.-J., Van Cutsem, E., Feyereislova, A., Chung, H. C., Shen, L., Sawaki, A., Lordick, F., Ohtsu, A., Omuro, Y., Satoh, T., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61121-x · Cited by 7,302
Self-citationComprehensive molecular characterization of gastric adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13480 · Cited by 6,498
LAURÉN, P. (1965) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/apm.1965.64.1.31 · Cited by 6,133
Global Cancer Incidence and Mortality Rates and Trends—An Update
Torre, L. A., Siegel, R. L., Ward, E. M., & Jemal, A. (2016) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0578 · Cited by 3,692
ESPEN Guidelines for Nutrition Screening 2002
Kondrup, J. (2003) · Clinical Nutrition · doi:10.1016/s0261-5614(03)00098-0 · Cited by 3,159
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
Wilke, H., Muro, K., Van Cutsem, E., Oh, S.-C., Bodoky, G., Shimada, Y., Hironaka, S., Sugimoto, N., Lipatov, O., Kim, T.-Y., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70420-6 · Cited by 2,438
Self-citationPennathur, A., Gibson, M. K., Jobe, B. A., & Luketich, J. D. (2013) · The Lancet · doi:10.1016/s0140-6736(12)60643-6 · Cited by 2,390
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
Cunningham, D., Starling, N., Rao, S., Iveson, T., Nicolson, M., Coxon, F., Middleton, G., Daniel, F., Oates, J., & Norman, A. R. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa073149 · Cited by 2,285
Kang, Y.-K., Boku, N., Satoh, T., Ryu, M.-H., Chao, Y., Kato, K., Chung, H. C., Chen, J.-S., Muro, K., Kang, W. K., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31827-5 · Cited by 2,252
Self-citationMolecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
Cristescu, R., Lee, J., Nebozhyn, M., Kim, K.-M., Ting, J. C., Wong, S. S., Liu, J., Yue, Y. G., Wang, J., Yu, K., et al. (2015) · Nature Medicine · doi:10.1038/nm.3850 · Cited by 2,223
Fuchs, C. S., Tomasek, J., Yong, C. J., Dumitru, F., Passalacqua, R., Goswami, C., Safran, H., dos Santos, L. V., Aprile, G., Ferry, D. R., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61719-5 · Cited by 2,188
Self-citationVan Cutsem, E., Moiseyenko, V. M., Tjulandin, S., Majlis, A., Constenla, M., Boni, C., Rodrigues, A., Fodor, M., Chao, Y., Voznyi, E., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.8429 · Cited by 1,926
Self-citationGastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention
Karimi, P., Islami, F., Anandasabapathy, S., Freedman, N. D., & Kamangar, F. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-1057 · Cited by 1,879
Koizumi, W., Narahara, H., Hara, T., Takagane, A., Akiya, T., Takagi, M., Miyashita, K., Nishizaki, T., Kobayashi, O., Takiyama, W., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70035-4 · Cited by 1,847
Fuchs, C. S., Doi, T., Jang, R. W., Muro, K., Satoh, T., Machado, M., Sun, W., Jalal, S. I., Shah, M. A., Metges, J.-P., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.0013 · Cited by 1,784
Self-citationKim, S. T., Cristescu, R., Bass, A. J., Kim, K.-M., Odegaard, J. I., Kim, K., Liu, X. Q., Sher, X., Jung, H., Lee, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0101-z · Cited by 1,654
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Okines, A., Verheij, M., Allum, W., Cunningham, D., & Cervantes, A. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq164 · Cited by 1,300
Chemotherapy for advanced gastric cancer
Wagner, A. D., Syn, N. L., Moehler, M., Grothe, W., Yong, W. P., Tai, B.-C., Ho, J., & Unverzagt, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004064.pub4 · Cited by 1,299
Self-citationShitara, K., Özgüroğlu, M., Bang, Y.-J., Di Bartolomeo, M., Mandalà, M., Ryu, M.-H., Fornaro, L., Olesiński, T., Caglevic, C., Chung, H. C., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31257-1 · Cited by 1,296
Self-citationRustgi, A. K., & El-Serag, H. B. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1314530 · Cited by 1,243
Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Lordick, F., Mariette, C., Haustermans, K., Obermannová, R., & Arnold, D. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw329 · Cited by 1,098
Self-citationLi, J., Qin, S., Xu, J., Xiong, J., Wu, C., Bai, Y., Liu, W., Tong, J., Liu, Y., Xu, R., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.5995 · Cited by 972
Self-citationGlimelius, B., Ekström, K., Hoffman, K., Graf, W., Sjödén, P.-O., Haglund, U., Svensson, C., Enander, L.-K., Linné, T., Sellsröm, H., et al. (1997) · Annals of Oncology · doi:10.1023/a:1008243606668 · Cited by 849
Lordick, F., Kang, Y.-K., Chung, H.-C., Salman, P., Oh, S. C., Bodoky, G., Kurteva, G., Volovat, C., Moiseyenko, V. M., Gorbunova, V., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70102-5 · Cited by 833
Self-citationGastric cancer: Asia and the world
Sano, T. (2017) · Gastric Cancer · doi:10.1007/s10120-017-0694-9 · Cited by 807
Ando, Y., Saka, H., Ando, M., Sawa, T., Muro, K., Ueoka, H., Yokoyama, A., Saitoh, S., Shimokata, K., & Hasegawa, Y. (2000) · PubMed · Cited by 783
Self-citationKang, Y.-K., Kang, W.-K., Shin, D.-B., Chen, J., Xiong, J., Wang, J., Lichinitser, M., Guan, Z., Khasanov, R., Zheng, L., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn717 · Cited by 764
Waddell, T., Chau, I., Cunningham, D., Gonzalez, D., Okines, A. F. C., Wotherspoon, A., Saffery, C., Middleton, G., Wadsley, J., Ferry, D., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70096-2 · Cited by 725
Fujitani, K., Yang, H.-K., Mizusawa, J., Kim, Y.-W., Terashima, M., Han, S.-U., Iwasaki, Y., Hyung, W. J., Takagane, A., Park, D. J., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00553-7 · Cited by 712
Kang, J. H., Lee, S. I., Lim, D. H., Park, K.-W., Oh, S. Y., Kwon, H.-C., Hwang, I. G., Lee, S.-C., Nam, E., Shin, D. B., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.4585 · Cited by 660
ESMO-magnitude of clinical benefit scale version 1.1
Cherny, N. I., Dafni, U., Bogaerts, J., Latino, N. J., Pentheroudakis, G., Douillard, J.-Y., Tabernero, J., Zielinski, C., Piccart, M. J., & de Vries, E. G. E. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx310 · Cited by 641
Self-citationDykewicz, C. A. (2001) · Clinical Infectious Diseases · doi:10.1086/321805 · Cited by 636
Recent patterns in gastric cancer: A global overview
Bertuccio, P., Chatenoud, L., Levi, F., Praud, D., Ferlay, J., Negri, E., Malvezzi, M., & La Vecchia, C. (2009) · International Journal of Cancer · doi:10.1002/ijc.24290 · Cited by 624
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas
Liu, Y., Sethi, N. S., Hinoue, T., Schneider, B. G., Cherniack, A. D., Sanchez-Vega, F., Seoane, J. A., Farshidfar, F., Bowlby, R., Islam, M., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.010 · Cited by 615
Self-citationThuss-Patience, P. C., Kretzschmar, A., Bichev, D., Deist, T., Hinke, A., Breithaupt, K., Dogan, Y., Gebauer, B., Schumacher, G., & Reichardt, P. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.06.002 · Cited by 612
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
Van Cutsem, E., Bang, Y.-J., Feng-yi, F., Xu, J. M., Lee, K.-W., Jiao, S.-C., Chong, J. L., López-Sanchez, R. I., Price, T., Gladkov, O., et al. (2015) · Gastric Cancer · doi:10.1007/s10120-014-0402-y · Cited by 608
Self-citationFord, H. E. R., Marshall, A., Bridgewater, J. A., Janowitz, T., Coxon, F. Y., Wadsley, J., Mansoor, W., Fyfe, D., Madhusudan, S., Middleton, G. W., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70549-7 · Cited by 595
Takeuchi, H., Miyata, H., Gotoh, M., Kitagawa, Y., Baba, H., Kimura, W., Tomita, N., Nakagoe, T., Shimada, M., Sugihara, K., et al. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000644 · Cited by 591
Yoshino, T., Arnold, D., Taniguchi, H., Pentheroudakis, G., Yamazaki, K., Xu, R.-H., Kim, T. W., Ismail, F., Tan, I. B., Yeh, K.-H., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdx738 · Cited by 573
Self-citationFlamen, P., Lerut, A., Van Cutsem, E., De Wever, W., Peeters, M., Stroobants, S., Dupont, P., Bormans, G., Hiele, M., De Leyn, P., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.18.3202 · Cited by 571
Self-citationEffectiveness of the korean national cancer screening program in reducing gastric cancer mortality
Jun, J. K., Choi, K. S., Lee, H.-Y., Suh, M., Park, B., Song, S. H., Jung, K. W., Lee, C. W., Choi, I. J., Park, E.-C., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.029 · Cited by 570
Yamada, Y., Higuchi, K., Nishikawa, K., Gotoh, M., Fuse, N., Sugimoto, N., Nishina, T., Amagai, K., Chìn, K., Niwa, Y., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu472 · Cited by 567
van der Post, R. S., Vogelaar, I. P., Carneiro, F., Guilford, P., Huntsman, D., Hoogerbrugge, N., Caldas, C., Chelcun Schreiber, K. E., Hardwick, R. H., Ausems, M. G. E. M., et al. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103094 · Cited by 561
Hironaka, S., Ueda, S., Yasui, H., Nishina, T., Tsuda, M., Tsumura, T., Sugimoto, N., Shimodaira, H., Tokunaga, S., Moriwaki, T., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.5805 · Cited by 541
Staging investigations for oesophageal cancer: a meta-analysis
van Vliet, E. P. M., Heijenbrok-Kal, M. H., Hunink, M. G. M., Kuipers, E. J., & Siersema, P. D. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604200 · Cited by 517
Shitara, K., Doi, T., Dvorkin, M., Mansoor, W., Arkenau, H.-T., Prokharau, A., Alsina, M., Ghidini, M., Faustino, C., Gorbunova, V., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30739-3 · Cited by 511
Self-citationHoms, M. Y., Steyerberg, E. W., Eijkenboom, W. M., Tilanus, H. W., Stalpers, L. J., Bartelsman, J. F., van Lanschot, J. J., Wijrdeman, H. K., Mulder, C. J., Reinders, J. G., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17272-3 · Cited by 507
Management of gastric cancer in Asia: resource-stratified guidelines
Shen, L., Shan, Y.-S., Hu, H.-M., Price, T. J., Sirohi, B., Yeh, K.-H., Yang, Y.-H., Sano, T., Yang, H.-K., Zhang, X., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70436-4 · Cited by 461
Self-citationAge-Specific Trends in Incidence of Noncardia Gastric Cancer in US Adults
Anderson, W. F. (2010) · JAMA · doi:10.1001/jama.2010.496 · Cited by 460
Lei, Z., Tan, I. B., Das, K., Deng, N., Zouridis, H., Pattison, S., Chua, C., Feng, Z., Guan, Y. K., Ooi, C. H., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.010 · Cited by 458
Kuwano, H., Nishimura, Y., Oyama, T., Kato, H., Kitagawa, Y., Kusano, M., Shimada, H., Takiuchi, H., Toh, Y., Doki, Y., et al. (2015) · Esophagus · doi:10.1007/s10388-014-0465-1 · Cited by 445
Global patterns of cardia and non-cardia gastric cancer incidence in 2012
Colquhoun, A., Arnold, M., Ferlay, J., Goodman, K. J., Forman, D., & Soerjomataram, I. (2015) · Gut · doi:10.1136/gutjnl-2014-308915 · Cited by 383
Asia–Pacific consensus guidelines on gastric cancer prevention
Fock, K. M., Talley, N., Moayyedi, P., Hunt, R., Azuma, T., Sugano, K., Xiao, S. D., Lam, S. K., Goh, K. L., Chiba, T., et al. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05314.x · Cited by 354
Catenacci, D. V. T., Tebbutt, N. C., Davidenko, I., Murad, A. M., Al-Batran, S.-E., Ilson, D. H., Tjulandin, S., Gotovkin, E., Karaszewska, B., Bondarenko, I., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30566-1 · Cited by 348
Dank, M., Zaluski, J., Barone, C., Valvere, V., Yalcin, S., Peschel, C., Wenczl, M., Goker, E., Cisar, L., Wang, K., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn166 · Cited by 343
de Martel, C., Forman, D., & Plummer, M. (2013) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2013.01.003 · Cited by 338
Dutton, S. J., Ferry, D. R., Blazeby, J. M., Abbas, H., Dahle-Smith, A., Mansoor, W., Thompson, J., Harrison, M., Chatterjee, A., Falk, S., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70024-5 · Cited by 324
Doi, T., Piha-Paul, S. A., Jalal, S. I., Saraf, S., Lunceford, J., Koshiji, M., & Bennouna, J. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.9846 · Cited by 318
Shah, M. A., Bang, Y.-J., Lordick, F., Alsina, M., Chen, M., Hack, S. P., Bruey, J. M., Smith, D., McCaffery, I., Shames, D. S., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5580 · Cited by 303
Self-citationBouché, O., Raoul, J. L., Bonnetain, F., Giovannini, M., Etienne, P. L., Lledo, G., Arsène, D., Paitel, J. F., Guérin-Meyer, V., Mitry, E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.140 · Cited by 274
Guimbaud, R., Louvet, C., Ries, P., Ychou, M., Maillard, E., André, T., Gornet, J.-M., Aparicio, T., Nguyen, S., Azzedine, A., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.1011 · Cited by 263
Okines, A. F. C., Norman, A. R., McCloud, P., Kang, Y.-K., & Cunningham, D. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp047 · Cited by 258
Shitara, K., Takashima, A., Fujitani, K., Koeda, K., Hara, H., Nakayama, N., Hironaka, S., Nishikawa, K., Makari, Y., Amagai, K., et al. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30219-9 · Cited by 217
Self-citationDesiderio, J., Chao, J., Melstrom, L., Warner, S., Tozzi, F., Fong, Y., Parisi, A., & Woo, Y. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.03.030 · Cited by 213
Muro, K., Van Cutsem, E., Narita, Y., Pentheroudakis, G., Baba, E., Li, J., Ryu, M. H., Zamaniah, W. I. W., Yong, W. P., Yeh, K. H., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdy502 · Cited by 213
Self-citationTrends in incidence of oesophageal and stomach cancer subtypes in Europe
Steevens, J., Botterweck, A. A. M., Dirx, M. J. M., van den Brandt, P. A., & Schouten, L. J. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32832ca091 · Cited by 191
Shah, M. A., Janjigian, Y. Y., Stoller, R., Shibata, S., Kemeny, M., Krishnamurthi, S., Su, Y. B., Ocean, A., Capanu, M., Mehrotra, B., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.60.7465 · Cited by 178
Clinical Practice Guidelines for Gastric Cancer in Korea: An Evidence-Based Approach
Lee, J. H., Kim, J. G., Jung, H.-K., Kim, J. H., Jeong, W. K., Jeon, T. J., Kim, J. M., Kim, Y. I., Ryu, K. W., Kong, S.-H., et al. (2014) · Journal of Gastric Cancer · doi:10.5230/jgc.2014.14.2.87 · Cited by 176
Hayashi, K. (2001) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hye090 · Cited by 176
The JACCRO and KCSG Study Group, Koizumi, W., Kim, Y. H., Fujii, M., Kim, H. K., Imamura, H., Lee, K. H., Hara, T., Chung, H. C., Satoh, T., et al. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-013-1563-5 · Cited by 175
Self-citationInterventions for dysphagia in oesophageal cancer
Yang, C., Li, J., Fu, W., Xu, W., & Yang, S. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005048.pub4 · Cited by 173
Self-citationAl-Batran, S.-E., Pauligk, C., Homann, N., Hartmann, J. T., Moehler, M., Probst, S., Rethwisch, V., Stoehlmacher-Williams, J., Prasnikar, N., Hollerbach, S., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.09.025 · Cited by 165
Divergent trends for gastric cancer incidence by anatomical subsite in US adults
Camargo, M. C., Anderson, W. F., King, J. B., Correa, P., Thomas, C. C., Rosenberg, P. S., Eheman, C. R., & Rabkin, C. S. (2011) · Gut · doi:10.1136/gut.2010.236737 · Cited by 164
Castro, C., Bosetti, C., Malvezzi, M., Bertuccio, P., Levi, F., Negri, E., Vecchia, C. L., & Lunet, N. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt486 · Cited by 150
Kurokawa, Y., Sugimoto, N., Miwa, H., Tsuda, M., Nishina, S., Okuda, H., Imamura, H., Gamoh, M., Sakai, D., Shimokawa, T., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.18 · Cited by 144
Gefitinib and EGFR Gene Copy Number Aberrations in Esophageal Cancer
Petty, R., Dahle-Smith, Å., Stevenson, D. A. J., Osborne, A., Massie, D., Clark, C., Murray, G. I., Dutton, S., Roberts, C., Chong, I. Y.-S., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.3934 · Cited by 142
Kim, G. M., Jeung, H., Rha, S. Y., Kim, H. S., Jung, I., Nam, B., Lee, K. H., & Chung, H. C. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.12.017 · Cited by 140
Ryu, M., Yoo, C., Kim, J. G., Ryoo, B., Park, Y. S., Park, S. R., Han, H., Chung, I. J., Song, E., Lee, K. H., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2014.12.015 · Cited by 137
Self-citationRoy, A. C., Park, S. R., Cunningham, D., Kang, Y., Chao, Y., Chen, L., Rees, C., Lim, H. Y., Tabernero, J. M., Ramos, F. J., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt002 · Cited by 136
Self-citationLee, J.-L., Kang, Y.-K., Kang, H. J., Lee, K.-H., Zang, D. Y., Ryoo, B.-Y., Kim, J. G., Park, S. R., Kang, W. K., Shin, D. B., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604536 · Cited by 134
Self-citationHiura, Y., Takiguchi, S., Yamamoto, K., Takahashi, T., Kurokawa, Y., Yamasaki, M., Nakajima, K., Miyata, H., Fujiwara, Y., Mori, M., et al. (2012) · Cancer · doi:10.1002/cncr.27430 · Cited by 122
Satoh, T., Ura, T., Yamada, Y., Yamazaki, K., Tsujinaka, T., Munakata, M., Nishina, T., Okamura, S., Esaki, T., Sasaki, Y., et al. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02030.x · Cited by 102
The role of palliative radiation therapy in symptomatic locally advanced gastric cancer
Tey, J. C. S., Back, M., Shakespeare, T. P., et al. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.08.070 · Cited by 102
Asakura, H., Hashimoto, T., Harada, H., Mizumoto, M., Furutani, K., Hasuike, N., Matsuoka, M., Ono, H., Boku, N., & Nishimura, T. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0866-z · Cited by 101
Miyata, H., Yano, M., Yasuda, T., Hamano, R., Yamasaki, M., Hou, E., Motoori, M., Shiraishi, O., Tanaka, K., Mori, M., et al. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2011.11.002 · Cited by 96
Yabuta, T., Shinmura, K., Tani, M., Yamaguchi, S., Yoshimura, K., Katai, H., Nakajima, T., Mochiki, E., Tsujinaka, T., Takami, M., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10633 · Cited by 94
Self-citationActionable gene-based classification toward precision medicine in gastric cancer
Ichikawa, H., Nagahashi, M., Shimada, Y., Hanyu, T., Ishikawa, T., Kameyama, H., Kobayashi, T., Sakata, J., Yabusaki, H., Nakagawa, S., et al. (2017) · Genome Medicine · doi:10.1186/s13073-017-0484-3 · Cited by 92
Le, D. T., Kavan, P., Kim, T. W., Burge, M. E., Van Cutsem, E., Hara, H., Boland, P. M., Van Laethem, J.-L., Geva, R., Taniguchi, H., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.36.15_suppl.3514 · Cited by 85
Self-citationShitara, K., Muro, K., Shimada, Y., Hironaka, S., Sugimoto, N., Komatsu, Y., Nishina, T., Yamaguchi, K., Segawa, Y., Omuro, Y., et al. (2015) · Gastric Cancer · doi:10.1007/s10120-015-0559-z · Cited by 84
Self-citationCheng, L., Li, M., Hu, J. Y., Ren, W., Xie, L., Sun, Z., Liu, B., Xu, G., Dong, X., & Qian, X. (2014) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2382-3 · Cited by 84
Al‐Batran, S., Cutsem, E. V., Oh, S. C., Bodoky, G., Shimada, Y., Hironaka, S., Sugimoto, N., Lipatov, O. N., Kim, T.-Y., Cunningham, D., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdv625 · Cited by 83
Self-citationPeng, J., Cai, J., Niu, Z., & Chen, L. (2015) · Diseases of the Esophagus · doi:10.1111/dote.12337 · Cited by 77
Self-citationThe Korean guideline for gastric cancer screening
Park, H. A., Nam, S. Y., Lee, S. K., Kim, S. G., Shim, K., Park, S. M., Lee, S., Han, H. S., Shin, Y. M., Kim, K., et al. (2015) · Journal of Korean Medical Association · doi:10.5124/jkma.2015.58.5.373 · Cited by 66
Lü, Z., Zhang, X., Liu, W., Liu, T., Hu, B., Li, W., Fan, Q., Xu, J., Xu, N., Bai, Y., et al. (2018) · Gastric Cancer · doi:10.1007/s10120-018-0809-y · Cited by 66
Diaz, L. A., Marabelle, A., Kim, T. W., Geva, R., Cutsem, E. V., André, T., Ascierto, P. A., Maio, M., Delord, J., Gottfried, M., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx367.020 · Cited by 65
Self-citationHiramoto, S., Kato, K., Shoji, H., Okita, N. T., Takashima, A., Honma, Y., Iwasa, S., Hamaguchi, T., Yamada, Y., Shimada, Y., et al. (2018) · International Journal of Clinical Oncology · doi:10.1007/s10147-018-1239-x · Cited by 59
Self-citationOkuyama, Y., Hazama, S., Nozawa, H., Kobayashi, M., Takahashi, K. P., Fujikawa, K., Kato, T., Nagata, N., Kimura, H., Oba, K., et al. (2011) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyr001 · Cited by 56
Bando, H., Yamada, Y., Tanabe, S., Nishikawa, K., Gotoh, M., Sugimoto, N., Nishina, T., Amagai, K., Chìn, K., Niwa, Y., et al. (2015) · Gastric Cancer · doi:10.1007/s10120-015-0549-1 · Cited by 53
Hwang, I. G., Ji, J. H., Kang, J. H., Lee, H. R., Lee, H.-Y., Chi, K., Park, S. W., Lee, S. J., Kim, S. T., Lee, J., et al. (2017) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2017.01.002 · Cited by 51
Yun, J., Lee, J., Park, S. H., Park, J. O., Park, Y. S., Lim, H. Y., & Kang, W. K. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.12.015 · Cited by 50
Bando, H., Doi, T., Muro, K., Yasui, H., Nishina, T., Yamaguchi, K., Takahashi, S., Nomura, S., Kuno, H., Shitara, K., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.04.009 · Cited by 49
Self-citationGenetic testing for UGT1A1*28 and *6 in Japanese patients who receive irinotecan chemotherapy
Akiyama, Y., Fujita, K., Nagashima, F., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn645 · Cited by 46
Miura, Y., Sukawa, Y., Hironaka, S., Mori, M., Nishikawa, K., Tokunaga, S., Okuda, H., Sakamoto, T., Taku, K., Nishikawa, K., et al. (2017) · Gastric Cancer · doi:10.1007/s10120-017-0725-6 · Cited by 45
Chen, Q., Yu, L., Hao, C., Wang, J., Liu, S., Zhang, M., Zhang, S., Guo, L., Quan, P., Germain, P., et al. (2016) · Scientific Reports · doi:10.1038/srep35707 · Cited by 36
Makiyama, A., Sagara, K., Kawada, J., Kashiwada, T., Hosokawa, A., Horie, Y., Satake, H., Yamamoto, Y., Tanioka, H., Shinozaki, K., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.36.15_suppl.4011 · Cited by 36
Self-citationSynopsis on Clinical Practice Guideline of Gastric Cancer in Korea: An Evidence-Based Approach
Lee, J. H., Kim, J. G., Kim, J. H., Kim, J. H., Jeong, W. K., Jeon, T. J., Kim, J. M., Kim, H., Ryu, K. W., Kong, S., et al. (2014) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2014.63.2.66 · Cited by 33
Xiang, X. J., Zhang, L., Qiu, F., Feng, Y. Y., Zhan, Z. Y., Feng, M., Yan, J., Zhao, J. G., & Xiong, J. P. (2012) · Chemotherapy · doi:10.1159/000335585 · Cited by 32
Zhao, J. G., Qiu, F. X., Xiong, J. P., Zhang, L., Xiang, X. J., Yu, F., Yan, J., Zhan, Z. Y., & Feng, M. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328324bbc1 · Cited by 31
ter Veer, E., Ngai, L. L., van Valkenhoef, G., Mohammad, N. H., Anderegg, M. C. J., van Oijen, M. G. H., & van Laarhoven, H. W. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-07750-3 · Cited by 29
Current status of immunotherapy and immune biomarkers in gastro-esophageal cancers
Ammannagari, N., & Atasoy, A. (2018) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2017.06.12 · Cited by 29
Dafni, U. G., Karlis, D., Pedeli, X., Bogaerts, J., Pentheroudakis, G. E., Tabernero, J. M., Zielinski, C. C., Piccart, M. J., de Vries, E. G. E., Latino, N. J., et al. (2017) · ESMO Open · doi:10.1136/esmoopen-2017-000216 · Cited by 29
Self-citationWang, J., Chang, J., Yu, H., Wu, X., Wang, H., Li, W., Ji, D., & Peng, W. J. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2081-5 · Cited by 28
Motoori, M., Yano, M., Yasuda, T., Miyata, H., Peng, Y. F., Yamasaki, M., Shiraishi, O., Tanaka, K., Ishikawa, O., Shiozaki, H., et al. (2012) · Oncology · doi:10.1159/000339694 · Cited by 24
Lu, Z., Li, Y., Yu, J., Lü, M., Li, J., Zhou, J., Wang, X., Gong, J., Gao, J., Zhang, X., et al. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.15.6047 · Cited by 23
Self-citationLiu, M., Hu, G., Wang, Y., Guo, J., Liu, L., Han, X., & Wang, Z. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s149624 · Cited by 14
Biomarkers and novel agents in esophago-gastric cancer: are we making progress?
Dahle-Smith, Å., & Petty, R. (2015) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2015.1071669 · Cited by 6
Cited by
Sun, J.-M., Shen, L., Shah, M. A., Enzinger, P., Adenis, A., Doi, T., Kojima, T., Metges, J.-P., Li, Z., Kim, S.-B., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01234-4 · Cited by 1,635
Self-citationTrastuzumab deruxtecan in previously treated HER2-positive gastric cancer
Shitara, K., Bang, Y.-J., Iwasa, S., Sugimoto, N., Ryu, M.-H., Sakai, D., Chung, H.-C., Kawakami, H., Yabusaki, H., Lee, J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2004413 · Cited by 1,333
Self-citationKato, K., Cho, B. C., Takahashi, M., Okada, M., Lin, C.-Y., Chin, K., Kadowaki, S., Ahn, M.-J., Hamamoto, Y., Doki, Y., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30626-6 · Cited by 1,213
Self-citationShitara, K., Van Cutsem, E., Bang, Y.-J., Fuchs, C., Wyrwicz, L., Lee, K.-W., Kudaba, I., Garrido, M., Chung, H. C., Lee, J., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.3370 · Cited by 1,141
Self-citationKojima, T., Shah, M. A., Muro, K., Francois, E., Adenis, A., Hsu, C.-H., Doi, T., Moriwaki, T., Kim, S.-B., Lee, S.-H., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.01888 · Cited by 1,126
Self-citation
Metadata
- Authors
- Muro, K., Lordick, F., Tsushima, T., Pentheroudakis, G., Baba, E., Lu, Z., Cho, B. C., Nor, I. M., Ng, M., Chen, L. T., Kato, K., Li, J., Ryu, M. H., Zamaniah, W. I. W., Yong, W. P., Yeh, K. H., Nakajima, T. E., Shitara, K., Kawakami, H., Narita, Y., Yoshino, T., Van Cutsem, E., Martinelli, E., Smyth, E. C., Arnold, D., Minami, H., Tabernero, J., & Douillard, J. Y.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2019-01
- Volume
- 30
- Issue
- 1
- Pages
- 34-43
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2900604868
- Cited by
- 289
- References
- 119
- FWCI
- 21.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.